Reduce Cell Bank Manufacturing Risk and Accelerate Characterization, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how closed processing and cell line characterization can help reduce risk in cell bank manufacturing. The featured speakers will discuss contamination control, testing requirements and characterization strategies for master and working cell banks. Attendees will also explore how integrated manufacturing and testing approaches can support regulatory alignment and reduce pressure on biologics development timelines.
TORONTO, Oct. 1, 2026 /PRNewswire/ -- The latest innovations in cell bank manufacturing can help accelerate biologic therapeutics program while reducing risk and simplifying overall strategy. As industry expectations continue to evolve, establishing a well-characterized cell bank requires careful consideration of manufacturing processes, contamination control, testing requirements and regulatory expectations. This webinar explores how closed processing and cell line characterization can support a regulatory-aligned pathway from GMP cell bank manufacturing through comprehensive characterization.
The featured speakers will highlight key enhancements to cell bank manufacturing approaches and explore how closed processing systems support closer alignment with changing industry expectations and reduce contamination risk. The discussion will also cover comprehensive upstream capabilities across cell banking and cell line characterization, providing insight into how these activities can be considered as part of an integrated development strategy.
This webinar will also examine next-generation cell line characterization for master cell banks, based on scientific rigor and appropriate risk assessments that address global regulatory guidance. It will provide pragmatic insights into evolving industry expectations and how innovative technologies, scientific expertise and integrated capabilities can establish a solid foundation for biologics programs.
Register for this webinar to learn how cell bank manufacturing can reduce contamination risk, support comprehensive characterization and strengthen biologics development programs.
Join experts from MilliporeSigma, Angela Waugh, Global Scientific Lead for Manufacturing; and Leyla Diaz, PhD, Technical Consultant, Scientific and Regulatory Consultancy, for the live webinar on Tuesday, October 20, 2026, at 10am EDT (4pm CEST / EU-Central).
For more information, or to register for this event, visit Reduce Cell Bank Manufacturing Risk and Accelerate Characterization.
ABOUT XTALKS
Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: skumar@xtalks.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/reduce-cell-bank-manufacturing-risk-and-accelerate-characterization-upcoming-webinar-hosted-by-xtalks-302895354.html
SOURCE Xtalks
